Animal models of Parkinson’s disease and L-dopa induced dyskinesia: How close are we to the clinic?

被引：0
|
作者：
Emma Lane
Stephen Dunnett
机构：
[1] Cardiff University,School of Bioscience
来源：
Psychopharmacology | 2008年 / 199卷
关键词：
Parkinson’s disease; L-dopa-induced dyskinesia; 6-OHDA lesioned rat; MPTP-treated primate; Animal models;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：303 / 312
页数：9
相关论文
共 50 条
  • [1] Animal models of Parkinson's disease and L-dopa induced dyskinesia: How close are we to the clinic?
    Lane, Emma
    Dunnett, Stephen
    PSYCHOPHARMACOLOGY, 2008, 199 (03) : 303 - 312
  • [2] L-dopa induced dyskinesia in Parkinson's disease
    Bastide, Matthieu F.
    Bezard, Erwan
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2015, 199 (2-3): : 201 - 212
  • [3] Animal Models of L-Dopa-Induced Dyskinesia in Parkinson's Disease
    Cenci, M. Angela
    Crossman, Alan R.
    MOVEMENT DISORDERS, 2018, 33 (06) : 889 - 899
  • [4] Molecular mechanism of L-Dopa induced dyskinesia in Parkinson's disease
    Subhani, F. U. -H.
    Subhani, A.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S118 - S119
  • [5] L-Dopa Induced Dystonia, Dyskinesia in Juvenile Parkinson's Disease
    El-Saadig, Sarah M. Misbah
    ANNALS OF NEUROLOGY, 2012, 72 : S91 - S91
  • [6] Molecular mechanism of L-Dopa induced dyskinesia in Parkinson's disease
    Subhani, F. U. -H.
    Subhani, A.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S89 - S90
  • [7] Contribution of striatal interneurons to L-DOPA induced dyskinesia development in an animal model of Parkinson's disease
    Gomez, G.
    Taravini, I. R.
    Murer, M. G.
    Gershanik, O. S.
    MOVEMENT DISORDERS, 2015, 30 : S34 - S34
  • [8] Reduction of L-DOPA-induced dyskinesia in animal models of Parkinson disease
    Nature Clinical Practice Neurology, 2009, 5 (2): : 62 - 62
  • [9] First candidates of susceptibility to l-dopa induced dyskinesia in parkinson's disease
    Charbonnier-Beaupel, F.
    Malerbi, M.
    Alcacer, C.
    Tahiri, K.
    Cormier, F.
    Carpentier, W.
    Herve, D.
    Girault, J. A.
    Corvol, J. C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 15 - 15
  • [10] Possible role for chlorpheniramine in the treatment of l-DOPA induced dyskinesia in Parkinson’s disease
    Petros N. Karamanakos
    Periklis Pappas
    Marios Marselos
    Pharmacy World & Science, 2008, 30 : 1 - 2
12345